Skip to main content
Clinical Trials/NCT00492479
NCT00492479TerminatedPhase 4

An Evaluation of Kinerase Pro+Therapy Regimen Vs. Kinerase Vs. Control for the Treatment of Skin Aging

Innovative Medical1 site in 1 countryStarted: June 1, 2007Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Terminated
Locations
1

Study Overview

Brief Summary

The purpose of this study is to compare the efficacy of the Kinerase Pro+Therapy regimen versus a single Kinerase product vs. control for the treatment of the signs of skin aging.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Masking
Single

Eligibility Criteria

Ages
35 Years to 55 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Female patients 35-55 years of age with at least moderate signs of facial aging
  • •Written informed consent
  • •Likely to complete all study visits and follow study protocol

Exclusion Criteria

  • •Any dermatological or medical condition which would make patient participation unsafe or interfere with study outcomes or measurements
  • •Known hypersensitivity to any study product or their components
  • •Recent (within 4 weeks of baseline) surgical treatment to face (including IPL and other laser procedures)
  • •Prior use of anti-aging treatments for 30 days prior to study entry (physician dispensed or prescribed treatments)
  • •Planned facial procedures during the study (microdermabrasion, facials, etc)
  • •o Botox and fillers cannot be used during the trial or for 3 months prior to study entry
  • •Recent (within 60 days) or concurrent participation in another clinical trial
  • •Concomitant topical or systemic therapy that my interfere with study measurements or outcomes
  • •Use of any other topical photoaging/antiaging therapies during the study, other than the prescribed study regimens
  • •Patients who are habitual tanners (outdoors or with tanning beds) who plan on tanning during the study
  • •Wearing of cosmetics during study visits

Investigators

Sponsor Class
Industry

Study Sites (1)

Loading locations...

Similar Trials